GOOD MORNING

Here’s everything you need to know today: There are currently 14,157 publicly traded companies in the United States and over 1000+ articles released about S&P500 companies alone every single day. Today we will be showing you our top 3 stock picks we have hand picked for this week:

1 year performance

1. BFLY - 343%

2. HIMS - 320%

3. OKLO - 266%

This Week (Here’s our top 3 stock picks)  

1. Butterfly Network Inc. (BFLY)

1 Year Performance: +343%

Category: Momentum

Market Cap: $850M

Company Info:

Butterfly Network is a healthcare technology company that has developed a portable, handheld ultrasound device powered by artificial intelligence, making medical imaging more accessible and affordable. Their Butterfly iQ device uses semiconductor technology to deliver high-quality diagnostic imaging through a smartphone app, enabling real-time patient assessments in various healthcare settings.

Why it’s a buy:

Butterfly Network Inc. (BFLY) is a buy due to its innovative Butterfly iQ device, a handheld ultrasound powered by artificial intelligence, which disrupts the traditional medical imaging market by making high-quality diagnostics more accessible and affordable.

The company has demonstrated strong financial growth, with Q3 2024 revenue of $20.6 million, marking a 33% year-over-year increase, and Q4 2024 revenue growth of approximately 35% year-over-year, indicating robust operational momentum.

Analysts project a 20% revenue growth over the next year, surpassing the industry average of 9.1%, reflecting confidence in Butterfly Network's strategic direction.

With the growing adoption of AI-driven medical devices and the increasing demand for portable, cost-effective imaging solutions, Butterfly Network is positioned to benefit from a rising trend in healthcare technology, making it a compelling investment for long-term growth.

Revenue:

2. Hims & Hers Health Inc. (HIMS)

1 Year Performance: +320%

Category: Growth

Market Cap: $8.1B

Company Info:

Hims and Hers Health is a telehealth company that provides accessible, affordable healthcare services through a digital platform, offering consultations, prescriptions, and wellness products. The company specializes in areas like sexual health, skincare, mental health, and hair loss treatments, using licensed medical professionals to deliver services via online consultations and at-home delivery.

Why it’s a buy:

Hims & Hers Health Inc. (HIMS) is a buy due to its robust financial performance and strategic initiatives in the telehealth sector.

In the third quarter of 2024, the company reported a 77% year-over-year revenue increase, reaching $401.6 million, driven by strong demand for its weight-loss treatments, including a compounded version of Novo Nordisk's semaglutide.

The subscriber base has grown to over 2 million, with more than half utilizing personalized solutions, indicating effective customer engagement.

Additionally, Hims & Hers plans to launch a generic version of Novo Nordisk's liraglutide by next year, aiming to expand its product offerings and market share.

These factors, combined with the company's innovative approach to healthcare, position Hims & Hers for sustained growth and make it a compelling investment opportunity.

Revenue:

3. OKLO Inc. (OKLO)

1 Year Performance: +266%

Category: Momentum

Market Cap: $5.1B

Company Info:

Oklo is a nuclear energy startup developing compact, advanced reactors that use innovative, molten salt-based technology to generate clean energy. These small modular reactors aim to provide reliable, low-cost power while significantly reducing the environmental footprint and waste associated with traditional nuclear energy.

Why it’s a buy:

Oklo is a buy due to its innovative approach in the nuclear energy sector with its small modular reactors (SMRs), which are poised to revolutionize the industry by providing clean, reliable, and affordable energy.

As global demand for carbon-free power increases, Oklo’s molten salt-based reactor technology could meet growing energy needs while addressing concerns around waste and safety.

The company is positioning itself as a leader in the next generation of nuclear power, supported by a strong focus on environmental sustainability and the backing of prominent investors.

However, it's important to note that Oklo is currently a pre-revenue company, and its financial performance is still in the early stages.

The company has yet to generate significant revenue, and its earnings have been declining at an average annual rate of -135.3%, while the Electric Utilities industry saw earnings growing at 6% annually.

As governments and companies ramp up their efforts to combat climate change, Oklo is well-positioned to benefit from increasing investments in clean energy solutions, making it a compelling investment opportunity for the future.

Chart:

Get more picks like Hims & Hers Health…

If you are interested in receiving more of our top stock picks like HIMS sign up to our Elite Membership where you get access to:

• The ability to choose which stocks you want to receive (value stocks, dividend stocks, momentum stocks, etc.)

• 3 curated emails a week (monday, wednesday, friday) with 2 hand-picked stocks from your chosen category in each email

• 1 report a week (sunday) on the general market and state of where the stock market is it currently

• Direct email contact with myself to ask any questions regarding stock knowledge

• Exclusive offers from any of our partners (trade software, brokers, news sources, etc.)

• 2 week money back guarantee (100% refund)

Join today for only $4.99/month or $44.99/year. 

Otherwise, stay tuned for our next free release at 8:15 am EST (Monday and Friday).

Our Partners:

The #1 Trading Software in the world: Tradingview 

Thank you for your time!

I’m sure you get hundreds of emails a day so I thank you for taking the time to read ours. Please follow us on our social media channels below where we post other new and different content related to investing, personal finance, and trading. 

Stay tuned for our next free release at 8:15 am EST (Monday and Friday).